GSE115384 CELSR2 knockdown 6 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE115384_CELSR2 knockdown_6_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE115384_CELSR2 knockdown_6_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE115384_CELSR2 knockdown_6_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE115384_CELSR2 knockdown_6_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

acetylserotonin O-methyltransferase like

Gene

ribosomal protein S18

Gene

synergin gamma

Gene

growth arrest specific 5

Gene

small nucleolar RNA host gene 29

Gene

small nucleolar RNA host gene 16

Gene

long intergenic non-protein coding RNA 665

Gene

protein phosphatase 2 regulatory subunit B''beta

Gene

P2Y receptor family member 8

Gene

CENPB DNA-binding domains containing 2, pseudogene

  • Gene

    acetylserotonin O-methyltransferase like


  • Gene

    ribosomal protein S18



  • Gene

    growth arrest specific 5


  • Gene

    small nucleolar RNA host gene 29


  • Gene

    small nucleolar RNA host gene 16


  • Gene

    long intergenic non-protein coding RNA 665


  • Gene

    protein phosphatase 2 regulatory subunit B''beta


  • Gene

    P2Y receptor family member 8


  • Gene

    CENPB DNA-binding domains containing 2, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.